Cargando…

Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How?

Detalles Bibliográficos
Autores principales:	Park, Jin Sup, Jeong, Young-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989794/ https://www.ncbi.nlm.nih.gov/pubmed/35388998 http://dx.doi.org/10.4070/kcj.2022.0022

Ejemplares similares

In search of the optimal proteosome inhibitor. How, when and for whom?
por: Engelhardt, Monika, et al.
Publicado: (2021)

Freeze-all, for whom, when, and how
por: Celada, Paula, et al.
Publicado: (2020)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

Non-invasive ventilation in the ED: Whom, When, How?
por: Göksu, Erkan, et al.
Publicado: (2018)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Prone position in ARDS patients: why, when, how and for whom
por: Guérin, Claude, et al.
Publicado: (2020)

Pediatric Percutaneous Endoscopic Gastrostomy in Korea - When? By Whom? How?
por: Lee, Yoon
Publicado: (2022)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
por: Weseler, Antje R., et al.
Publicado: (2023)

Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
por: Jourde-Chiche, Noémie, et al.
Publicado: (2023)

Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?
por: Carrero, Juan J, et al.
Publicado: (2022)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How
por: Pavanello, Francesca, et al.
Publicado: (2016)

Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
por: Sullivan, Zachary P., et al.
Publicado: (2022)

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?
por: Salagre, Estela, et al.
Publicado: (2022)

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs
por: Shin, Gyeongseon, et al.
Publicado: (2022)

Prescription for unguided mobile health applications
por: Moman, Rajat N., et al.
Publicado: (2021)

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
por: Na, Soo-Young, et al.
Publicado: (2021)

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
por: Atallah, Ehab, et al.
Publicado: (2020)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Parenteral nutrition in oxygen escalation/de-escalation in SARS-CoV. When and how?
por: Quintero O, Oscar Iván, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

Oncoplastic Breast Surgery: What, When and for Whom?
por: Macmillan, R. Douglas, et al.
Publicado: (2016)

COVID-19 patients: when and whom to ventilate?
por: Lal, Tusharindra, et al.
Publicado: (2020)

Midwifery continuity of care: A scoping review of where, how, by whom and for whom?
por: Bradford, Billie F., et al.
Publicado: (2022)

Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
por: Triantafyllopoulos, Georgios K, et al.
Publicado: (2016)

Emergency airway management – by whom and how?
por: Sollid, S. J. M., et al.
Publicado: (2016)

Salvage radiotherapy with or without hormone therapy: for whom and when?
por: Carrie, Christian
Publicado: (2017)

Laparoscopy in Blunt Abdominal Trauma: for Whom? When?and Why?
por: Justin, Viktor, et al.
Publicado: (2017)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

Genetic testing in focal segmental glomerulosclerosis: in whom and when?
por: Tato, Ana María, et al.
Publicado: (2023)

Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial
por: Komócsi, András, et al.
Publicado: (2023)

How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
por: Grass, G. Daniel, et al.
Publicado: (2016)

How, when, and for whom: decisions regarding remote neuropsychological assessment during the 2020 COVID-19 pandemic
por: Bloch, Ayala, et al.
Publicado: (2021)

Cardiomyopathy Induced by Artificial Cardiac Pacing: To Whom, When, Why, and How? Insights on Heart Failure Development
por: Ferrari, Andres Di Leoni, et al.
Publicado: (2023)

Exploring the Effects of Guided vs. Unguided Art Therapy Methods
por: Costa, Ana Maria, et al.
Publicado: (2020)

Heart Transplantation in Congenital Heart Disease: In Whom to Consider and When?
por: Attenhofer Jost, Christine H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0l0jnonk6am6tvmo27askjcvko